NASDAQ · WHOLESALE-MISCELLANEOUS NONDURABLE GOODS · SMALL CAP
Natural Health Trends Corp. NHTC
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$39.8M
▼ 7.4% vs FY2024
EPS · FY25
$-0.08
Dividend / sh · FY25
$0.80
Payout · FY25
-1044%
ROE · FY25
-3.1%
Net margin · FY25
-2.2%
Dividend coverage
-0.1×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 39.8M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
The company lost 2 cents on every revenue dollar this year.
Per share
USD -0.08
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-3.1%
Return on equity, FY2025
ROE
Operating margin-4.5%
Net margin-2.2%
Return on assets-1.9%
Each USD of equity lost 3 cents this year.
Returned to shareholders
USD 9.2M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 9.2M
Net buybacks—
Share of profit-1044.2%
Consecutive raises—
USD 9.2M in dividends went back to shareholders in a year without profit.
Growth
−8.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−6.8%
−8.5%
−17.3%
+3.5%
Dividend / share
+0.0%
+0.0%
+19.0%
Returned to shareholders
+0.3%
+0.2%
−6.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 38.4M
total assets, end of FY2025
Total assetsUSD 38.4M
EquityUSD 23.4M
CashUSD 6.8M
Current ratio2.50×
Equity funds 61% of total assets.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.2
0.2
0.3
0.3
0.1
0.1
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
Net income $B
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
−0.0
EPS, diluted $
−0.08
0.05
0.05
0.03
0.09
0.07
−0.52
2.74
2.09
4.83
3.82
1.61
0.36
0.23
0.21
−0.23
Dividend / sh $
0.80
0.80
0.80
0.80
0.80
0.80
0.64
2.77
1.52
0.61
0.14
0.03
·
·
·
·
Payout %
−1044
1611
1622
2919
842
1084
−131
102
73
13
4
2
·
·
·
·
ROE %
−3.1
1.5
1.2
0.6
1.7
1.2
−6.8
34.4
27.2
79.1
113.5
125.2
67.3
·
·
·
Shares out B
·
·
·
·
·
·
·
·
·
·
·
·
0.01
0.01
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
64 of 64
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed